QYResearch Reviewed: Global market of BCG Vaccine developed rapidly, with an average growth rate of 5.74%
More Info: http://www.qyresearchglobal.com/goods-675811.html QYR disclosed a new report-- 2017 Market Research Report on Global BCG Vaccine Industry. The 2017 Market Research Report on Global BCG Vaccine Industry is a professional and in-depth study on the current state of the BCG Vaccine market.
More Info: http://www.qyresearchglobal.com/goods-675811.html QYR disclosed a new report-- 2017 Market Research Report on Global BCG Vaccine Industry. The 2017 Market Research Report on Global BCG Vaccine Industry is a professional and in-depth study on the current state of the BCG Vaccine market.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>QYResearch</strong> <strong>Reviewed</strong>: <strong>Global</strong> <strong>market</strong> <strong>of</strong><br />
<strong>BCG</strong> <strong>Vaccine</strong> <strong>developed</strong> <strong>rapidly</strong>, <strong>with</strong> <strong>an</strong><br />
<strong>average</strong> <strong>growth</strong> <strong>rate</strong> <strong>of</strong> <strong>5.74%</strong><br />
QYRESEARCH FOCUS ON MARKET SURVEY AND RESEARCH<br />
www.qyresearch.com
Beijing Hengzhou Bozhi International<br />
Information Consulting<br />
Web: qyresearchglobal.com | qyresearcheurope.com |<br />
qyresearch.com | qyresearch.com/english |<br />
qyresearchjap<strong>an</strong>.com<br />
TEL:+86-13660489419, Office:+86-2086655165<br />
Media: press@qyresearch.com<br />
Marketing: sales@qyresearch.com<br />
Facebook: @<strong>QYResearch</strong>Official,<br />
Twitter: @<strong>QYResearch</strong>_<br />
Wechat Official Account: <strong>QYResearch</strong>, Weibo: 恒 州 博 智<br />
www.qyresearch.com
<strong>QYResearch</strong><br />
<strong>BCG</strong> <strong>Vaccine</strong> is a vaccine primarily used against<br />
tuberculosis. Tuberculosis is a serious infection,<br />
which affects the lungs <strong>an</strong>d sometimes other parts<br />
<strong>of</strong> the body, such as the bones, joints <strong>an</strong>d kidneys.<br />
The bacille Calmette-Guérin (<strong>BCG</strong>) vaccine has<br />
existed for 80 years <strong>an</strong>d is one <strong>of</strong> the most widely<br />
used <strong>of</strong> all current vaccines, reading >80%<strong>of</strong><br />
neonates <strong>an</strong>d inf<strong>an</strong>ts in countries where it is part <strong>of</strong><br />
the national childhood immunization programme.<br />
Besides, <strong>BCG</strong> <strong>Vaccine</strong> is also used to treat a certain<br />
type <strong>of</strong> bladder c<strong>an</strong>cer. Bladder c<strong>an</strong>cer is the<br />
<strong>growth</strong> <strong>of</strong> abnormal or c<strong>an</strong>cerous cells on the inner<br />
lining <strong>of</strong> the bladder wall. <strong>BCG</strong> helps prevent the<br />
c<strong>an</strong>cer from coming back in the bladder lining, <strong>an</strong>d<br />
also reduces the risk <strong>of</strong> it becoming invasive.<br />
www.qyresearch.com
<strong>QYResearch</strong><br />
According to <strong>QYResearch</strong>, In the last several years, <strong>Global</strong> <strong>market</strong> <strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong><br />
<strong>developed</strong> <strong>rapidly</strong>, <strong>with</strong> <strong>an</strong> <strong>average</strong> <strong>growth</strong> <strong>rate</strong> <strong>of</strong> <strong>5.74%</strong>. In 2016, <strong>Global</strong> revenue<br />
<strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong> is about 261.43 M USD. The global <strong>average</strong> gross margin <strong>of</strong> <strong>BCG</strong><br />
<strong>Vaccine</strong> is in <strong>an</strong> decreasing trend, from 71.59% in 2012 to 69.46% in 2017. With<br />
the situation <strong>of</strong> global economy, gross margin will be in decreasing trend in the<br />
following five years.<br />
The type <strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong> includes Immune <strong>BCG</strong> <strong>an</strong>d Therapy <strong>BCG</strong>. The proportion <strong>of</strong><br />
Therapy <strong>BCG</strong> in 2016 is about 92.73%.<br />
<strong>BCG</strong> <strong>Vaccine</strong> is widely used in Hospitals <strong>an</strong>d Clinics. The most proportion <strong>of</strong> <strong>BCG</strong><br />
<strong>Vaccine</strong> is sold in Hospitals <strong>an</strong>d the <strong>market</strong> share in 2016 is about 74.14%, <strong>an</strong>d the<br />
Hospitals have upstream trend.<br />
www.qyresearch.com
<strong>QYResearch</strong><br />
North America is the largest supplier<br />
<strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong>, <strong>with</strong> a production<br />
<strong>market</strong> share nearly 32.58% in 2016.<br />
Europe is the second largest supplier <strong>of</strong><br />
<strong>BCG</strong> <strong>Vaccine</strong> Media, enjoying production<br />
<strong>market</strong> share nearly 29.74% in 2016.<br />
North America region is the largest<br />
consumption <strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong>, <strong>with</strong> a<br />
sales revenue <strong>market</strong> share nearly<br />
36.40% in 2016. Europe is the second<br />
largest consumer <strong>of</strong> <strong>BCG</strong> <strong>Vaccine</strong>,<br />
enjoying sales revenue <strong>market</strong> share<br />
about 32.43% in 2016.<br />
www.qyresearch.com<br />
www.qyresearch.com
<strong>QYResearch</strong><br />
Market competition is not intense.<br />
Merck, S<strong>an</strong><strong>of</strong>i Pasteur, Jap<strong>an</strong> <strong>BCG</strong><br />
Lab, China National Biotec, Serum<br />
Institute <strong>of</strong> India, Intervax,<br />
GSBPL are the leaders <strong>of</strong> the<br />
industry, <strong>an</strong>d they have been<br />
formed in the monopoly position in<br />
the industry.<br />
www.qyresearch.com
Change language